Member

directonpc

Ebola Vaccine tested on monkeys and Worked!

Aug 25 2014 at 10:00pm

Nova Scotia - Four monkeys survived the Ebola virus after

being injected with Immunovaccine Inc's experimental

vaccine, the tiny Canadian company said on Monday, an

announcement that sent its stock soaring.

The Halifax, Nova Scotia-based company said four monkeys

received its vaccine and later survived a dose of Ebola virus

that normally would have been lethal. Two other animals

that did not receive the vaccine died within a week.

Also read: The new Ebola vaccine - some details

The tests were performed by the U.S. Health Department's

National Institutes of Health, based in Maryland.

Immunovaccine, which had a market capitalization of about

C$77 million as of Friday, is one of a handful of companies

testing potential vaccines for the Ebola virus, which has

killed nearly 1,500 people in West Africa.

Other companies testing Ebola vaccines include U.S.-based

NewLink Genetics Corp, which holds the licence for a

vaccine developed by the Canadian government, and

privately held Profectus BioSciences.

Immunovaccine said it is exploring options to develop the

vaccine with various organizations. The company is also

developing therapies for cancer and a vaccine for anthrax.

Its stock on the TSX Venture Exchange jumped as much as

44 percent, and was up 26.8 percent at C$1.23 around

midday, after a trading halt.



source news24